Prediction of reclassification at repeat biopsy with [-2]proPSA during active surveillance for low-risk prostate cancer: Prospective longitudinal analysis of a Japanese multicenter study cohort.

被引：0
|
作者：
Sugimoto, Mikio
Hirama, Hiromi
Ito, Kazuto
Shiraishi, Taizo
Kakehi, Yoshiyuki
机构：
[1] Kagawa Univ, Dept Urol, Fac Med, Takamatsu, Kagawa 760, Japan
[2] Gunma Univ, Dept Urol, Fac Med, Gunma, Japan
[3] Mie Univ, Dept Pathol Oncol, Grad Sch Med, Tsu, Mie, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16054
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Radical Prostatectomy for Low-Risk Prostate Cancer Following Initial Active Surveillance: Results From a Prospective Observational Study
    Bul, Meelan
    Zhu, Xiaoye
    Rannikko, Antti
    Staerman, Frederic
    Valdagni, Riccardo
    Pickles, Tom
    Bangma, Chris H.
    Roobol, Monique J.
    EUROPEAN UROLOGY, 2012, 62 (02) : 195 - 200
  • [42] RELATIONSHIP BETWEEN THE CONTINUITY AND DISCONTINUITY OF TWO POSITIVE CORES IN PROSTATE BIOPSY SPECIMENS FOR THE PREDICTION OF LOW-RISK PROSTATE CANCER AND IDENTIFICATION OF CANDIDATES FOR ACTIVE SURVEILLANCE
    Yoo, Sangjun
    Lee, Chanwoo
    Sohn, Mooyoung
    Lee, Chunwoo
    Hong, Sungwoo
    Kim, Hyung Jee
    Song, Sang Hoon
    Kim, Kun Suk
    You, Dalsan
    Kwon, Taekmin
    Jeong, In Gab
    Park, Sungchan
    Moon, Kyung Hyun
    Hong, Jun Hyuk
    Ahn, Hanjong
    Kim, Choung-Soo
    JOURNAL OF UROLOGY, 2015, 193 (04): : E1002 - E1003
  • [43] Prospective Pilot Trial of Daily Vitamin D Supplementation in the Active Surveillance of Low-Risk Prostate Cancer
    Cannick, L.
    Marshall, D. T.
    Savage, S. J.
    Garrett-Mayer, E.
    Ambrose, L. H.
    Gattoni-Celli, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S411 - S411
  • [44] Re: Tailoring Intensity of Active Surveillance for Low-Risk Prostate Cancer Based on Individualized Prediction of Risk Stability
    不详
    JOURNAL OF UROLOGY, 2021, 205 (01): : 304 - 305
  • [45] EVALUATION OF MRI/ULTRASOUND-FUSION BIOPSY IN PATIENTS WITH LOW-RISK PROSTATE CANCER UNDER ACTIVE SURVEILLANCE
    Borkowetz, Angelika
    Platzek, Ivan
    Toma, Marieta
    Renner, Theresa
    Baunacke, Martin
    Froehner, Michael
    Zastrow, Stefan
    Wirth, Manfred
    JOURNAL OF UROLOGY, 2017, 197 (04): : E219 - E220
  • [46] Outcomes of serial MRI/ultrasound fusion targeted biopsy in men with very low-risk and low-risk prostate cancer managed with active surveillance.
    Hsiang, Walter
    Ghabili, Kamyar
    Syed, Jamil
    Nguyen, Kevin
    Suarez-Sarmiento, Alfredo
    Leapman, Michael
    Sprenkle, Preston
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [47] African American Race is Not Associated with Risk of Reclassification during Active Surveillance: Results from the Canary Prostate Cancer Active Surveillance Study
    Schenk, Jeannette M.
    Newcomb, Lisa F.
    Zheng, Yingye
    Faino, Anna V.
    Zhu, Kehao
    Nyame, Yaw A.
    Brooks, James D.
    Carroll, Peter R.
    Cooperberg, Matthew R.
    Dash, Atreya
    Filson, Christopher P.
    Gleave, Martin E.
    Liss, Michael
    Martin, Francis M.
    Morgan, Todd M.
    Nelson, Peter S.
    Thompson, Ian M.
    Wagner, Andrew A.
    Lin, Daniel W.
    JOURNAL OF UROLOGY, 2020, 203 (04): : 727 - 732
  • [48] Quantifying the tradeoffs of active surveillance for low-risk prostate cancer: A clinical decision analysis.
    Liu, D.
    Lehmann, H. P.
    Frick, K. D.
    Carter, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [49] Active Surveillance Compared With Initial Treatment for Men With Low-Risk Prostate Cancer A Decision Analysis
    Hayes, Julia H.
    Ollendorf, Daniel A.
    Pearson, Steven D.
    Barry, Michael J.
    Kantoff, Philip W.
    Stewart, Susan T.
    Bhatnagar, Vibha
    Sweeney, Christopher J.
    Stahl, James E.
    McMahon, Pamela M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (21): : 2373 - 2380
  • [50] Cost-effectiveness Analysis of Active Surveillance Strategies for Men with Low-risk Prostate Cancer
    Sathianathen, Niranjan J.
    Konety, Badrinath R.
    Alarid-Escudero, Fernando
    Lawrentschuk, Nathan
    Bolton, Damien M.
    Kuntz, Karen M.
    EUROPEAN UROLOGY, 2019, 75 (06) : 910 - 917
12345